Iatrogenic Injuries Related to Thermal Ablation of the Liver and Pancreas

Abstract

Thermal ablation is a widely utilized treatment option for tumors of the liver and pancreas; procedures may be performed intraoperatively or percutaneously, under image guidance (more recently, endoscopy-guided ablation of pancreatic tumors has also been introduced). Through differing mechanisms, radiofrequency ablation, microwave ablation, and cryoablation aim to precisely eradicate tumor, with adequate margins and minimal injury to normal surrounding tissue. Knowledge of thermal ablative risks and complications is crucial for both therapeutic planning and postprocedural management to optimize outcomes and avoid significant patient injury. In this review, we discuss iatrogenic injuries related to thermal ablation of hepatic and pancreatic malignancies.

Keywords

complications - thermal - ablation - imaging

Publikationsverlauf

Eingereicht: 12. Dezember 2022

Angenommen: 10. Januar 2023

Artikel online veröffentlicht:
04. April 2023

• References

• 1 Kim KR, Thomas S. Complications of image-guided thermal ablation of liver and kidney neoplasms. Semin Intervent Radiol 2014; 31 (02) 138-148
• 2 Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S179-S186
• 3 Crocetti L, Scalise P, Lencioni R. Thermal ablation of liver lesions. In: Mauro MA, Murphy KP, Thomson KR, Venbrux AC, Morgan RA. eds. Expert Radiology: Image-Guided Interventions. 3rd ed.. Elsevier: 2020: 787-794.e3
• 4 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S192-S203
• 5 Smolock AR, Shaw C. Hepatic microwave ablation in challenging locations. Semin Intervent Radiol 2019; 36 (05) 392-397
• 6 Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S187-S191
• 7 Garnon J, Cazzato RL, Caudrelier J. et al. Adjunctive thermo-protection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol 2019; 42 (03) 344-357
• 8 Li M, Yu XL, Liang P, Liu F, Dong B, Zhou P. Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia 2012; 28 (03) 218-226
• 9 Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23 (02) 109-113 , discussion 113–114
• 10 Ladd AP, Rescorla FJ, Baust JG, Callahan M, Davis M, Grosfeld JL. Cryosurgical effects on growing vessels. Am Surg 1999; 65 (07) 677-682
• 11 Ko SE, Lee MW, Rhim H. et al. Comparison of procedure-related complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma. Int J Hyperthermia 2020; 37 (01) 1354-1361
• 12 Li M, Yu X, Liang P, Dong B, Liu F. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia 2015; 31 (06) 579-587
• 13 Huang H, Liang P, Yu XL. et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia 2015; 31 (01) 40-47
• 14 Patel PA, Ingram L, Wilson IDC, Breen DJ. No-touch wedge ablation technique of microwave ablation for the treatment of subcapsular tumors in the liver. J Vasc Interv Radiol 2013; 24 (08) 1257-1262
• 15 Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226 (02) 441-451
• 16 Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology 2002; 225 (02) 367-377
• 17 Shibata T, Yamamoto Y, Yamamoto N. et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 2003; 14 (12) 1535-1542
• 18 Yousaf MN, Ehsan H, Muneeb A. et al. Role of radiofrequency ablation in the management of unresectable pancreatic cancer. Front Med (Lausanne) 2021; 7: 624997
• 19 Mirza AN, Fornage BD, Sneige N. et al. Radiofrequency ablation of solid tumors. Cancer J 2001; 7 (02) 95-102
• 20 Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB (Oxford) 2006; 8 (01) 61-64
• 21 Rombouts SJ, Vogel JA, van Santvoort HC. et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg 2015; 102 (03) 182-193
• 22 Fegrachi S, Molenaar IQ, Klaessens JH, Besselink MG, Offerhaus JA, van Hillegersberg R. Radiofrequency ablation of the pancreas: two-week follow-up in a porcine model. Eur J Surg Oncol 2014; 40 (08) 1000-1007